Harmonicare Medical Holdings Limited announced unaudited consolidated earnings results for the six months ended 30 June 2018. For the period the company reported, revenue from goods and services was RMB 508,527,000 against RMB 422,652,000 a year ago. Loss before tax was RMB 25,343,000 against profit before tax of RMB 14,899,000 a year ago. Loss for the period was RMB 26,910,000 against profit for the period of RMB 11,218,000 a year ago. Loss for the period attributable to owners of the company was RMB 25,264,000 or 3.38 cents per basic and diluted share against profit for the period attributable to owners of the company of RMB 11,402,000 or 1.50 cents per basic and diluted share a year ago. Capital expenditure contracted for but not provided in the condensed consolidated financial statements in respect of acquisition of property, plant and equipment was RMB 186,649,000 against RMB 271,886,000 a year ago. The decrease in the net profit attributable to owners of the company was primarily due to the increased efforts by the group of professional talent resources and promotion to improve the brand influence, leading to a relatively significant increase in labor costs and marketing expenses; the increase in administrative expenses by RMB 10.48 million compared with that of the Corresponding Period in 2017 due to further progress in preparation for construction of new hospitals; and the recognized share of losses of associates of RMB 8.06 million, representing an increase of RMB 6.63 million compared with the corresponding period in 2017.